Skip to main content
. Author manuscript; available in PMC: 2013 Sep 6.
Published in final edited form as: BioDrugs. 2009;23(3):137–153. doi: 10.2165/00063030-200923030-00001

Table 2.

Vaccination strategies and resulting NAb response in clinical trials.

Vaccination Approach Rationale Result Reference
Subunit Protein Subunit based immunizations have been successfully used to raise antibody responses to a number of pathogens Narrow NAb responses with no protective efficacy [34, 35]
Viral Vectors Raise a balanced T and B cell response Narrow, low titer NAb responses elicited, when observed at all [79, 80]
DNA Vaccines Raise a balanced T and B cell response No NAb responses elicited [8587]
Viral Vector + Protein Viruses alone elicited only low quality antibody responses that may be boosted with a recombinant protein Increase in NAb titers with administration of protein boost [80]
DNA + Viral Vectors Adenoviruses may be capable of boosting low titer immune responses resulting from DNA priming Increased potency but still limited breadth of NAb [90]
DNA + Protein DNA immunizations can successfully prime a humoral response which can be augmented by boosting with a subunit protein Low titer, but broad NAb responses against a wide range of primary isolates [120]